Advertisement

Index by author

July 01, 1994; Volume 46,Issue 1

A

  1. Achkar, C

    1. Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases.
      M Chen, C Achkar and L J Gudas
      Molecular Pharmacology July 1994, 46 (1) 88-96;

  2. Adesnik, M

    1. Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells.
      P M Shaw, M C Weiss and M Adesnik
      Molecular Pharmacology July 1994, 46 (1) 79-87;

  3. Albuquerque, E X

    1. 9-Aminoacridines act at a site different from that for Mg2+ in blockade of the N-methyl-D-aspartate receptor channel.
      M E Nelson and E X Albuquerque
      Molecular Pharmacology July 1994, 46 (1) 151-160;

  4. Alexandrova, N

    1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
      N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
      Molecular Pharmacology July 1994, 46 (1) 73-78;

  5. Allan, W P

    1. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
      M K Ritke, W P Allan, C Fattman, N N Gunduz and J C Yalowich
      Molecular Pharmacology July 1994, 46 (1) 58-66;

  6. Anthony, M L

    1. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
      M L Anthony, B C Sweatman, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology July 1994, 46 (1) 199-211;

  7. Ashford, M L

    1. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
      K Lee, S E Ozanne, I C Rowe, C N Hales and M L Ashford
      Molecular Pharmacology July 1994, 46 (1) 176-185;

B

  1. Bakthavachalam, V

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;

  2. Beddell, C R

    1. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
      M L Anthony, B C Sweatman, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology July 1994, 46 (1) 199-211;

  3. Ben-Baruch, N

    1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
      N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
      Molecular Pharmacology July 1994, 46 (1) 73-78;

  4. Blake, M

    1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
      N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
      Molecular Pharmacology July 1994, 46 (1) 73-78;

  5. Bosch, S

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;

  6. Boyer, J L

    1. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
      T M Filtz, Q Li, J L Boyer, R A Nicholas and T K Harden
      Molecular Pharmacology July 1994, 46 (1) 8-14;

C

  1. Caron, M G

    1. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
      C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood
      Molecular Pharmacology July 1994, 46 (1) 51-57;

  2. Chen, M

    1. Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases.
      M Chen, C Achkar and L J Gudas
      Molecular Pharmacology July 1994, 46 (1) 88-96;

  3. Chignell, C F

    1. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
      P J Hayden, K E Free and C F Chignell
      Molecular Pharmacology July 1994, 46 (1) 186-198;

  4. Christopoulos, A

    1. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
      A Christopoulos and F Mitchelson
      Molecular Pharmacology July 1994, 46 (1) 105-114;

D

  1. Delesque, N

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

  2. De Weille, J

    1. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
      E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri
      Molecular Pharmacology July 1994, 46 (1) 139-145;

  3. Dilger, J P

    1. Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel.
      J P Dilger and A M Vidal
      Molecular Pharmacology July 1994, 46 (1) 169-175;

  4. Diz, D

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;

E

  1. Ellinwood, E H

    1. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
      C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood
      Molecular Pharmacology July 1994, 46 (1) 51-57;

  2. Emoto, Y

    1. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
      S Kharbanda, Y Emoto, H Kisaki, A Saleem and D Kufe
      Molecular Pharmacology July 1994, 46 (1) 67-72;

  3. Esteve, J P

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

F

  1. Farb, D H

    1. 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons.
      M Park-Chung, F S Wu and D H Farb
      Molecular Pharmacology July 1994, 46 (1) 146-150;

  2. Fattman, C

    1. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
      M K Ritke, W P Allan, C Fattman, N N Gunduz and J C Yalowich
      Molecular Pharmacology July 1994, 46 (1) 58-66;

  3. Filtz, T M

    1. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
      T M Filtz, Q Li, J L Boyer, R A Nicholas and T K Harden
      Molecular Pharmacology July 1994, 46 (1) 8-14;

  4. Fosset, M

    1. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
      E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri
      Molecular Pharmacology July 1994, 46 (1) 139-145;

  5. Free, K E

    1. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
      P J Hayden, K E Free and C F Chignell
      Molecular Pharmacology July 1994, 46 (1) 186-198;

G

  1. Goberna, R

    1. Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking.
      V Sánchez-Margalet, M Valle and R Goberna
      Molecular Pharmacology July 1994, 46 (1) 24-29;

  2. Gudas, L J

    1. Enzymatic conversion of retinaldehyde to retinoic acid by cloned murine cytosolic and mitochondrial aldehyde dehydrogenases.
      M Chen, C Achkar and L J Gudas
      Molecular Pharmacology July 1994, 46 (1) 88-96;

  3. Guillemare, E

    1. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
      E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri
      Molecular Pharmacology July 1994, 46 (1) 139-145;

  4. Gunduz, N N

    1. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
      M K Ritke, W P Allan, C Fattman, N N Gunduz and J C Yalowich
      Molecular Pharmacology July 1994, 46 (1) 58-66;

H

  1. Hales, C N

    1. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
      K Lee, S E Ozanne, I C Rowe, C N Hales and M L Ashford
      Molecular Pharmacology July 1994, 46 (1) 176-185;

  2. Harden, T K

    1. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
      T M Filtz, Q Li, J L Boyer, R A Nicholas and T K Harden
      Molecular Pharmacology July 1994, 46 (1) 8-14;

  3. Hayden, P J

    1. Structure-activity relationships for the formation of secondary radicals and inhibition of keratinocyte proliferation by 9-anthrones.
      P J Hayden, K E Free and C F Chignell
      Molecular Pharmacology July 1994, 46 (1) 186-198;

  4. Honore, E

    1. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
      E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri
      Molecular Pharmacology July 1994, 46 (1) 139-145;

I

  1. Ichinose, I

    1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
      N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
      Molecular Pharmacology July 1994, 46 (1) 73-78;

  2. Ignarro, L J

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

  3. Ivkovic, B

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;

K

  1. Kharbanda, S

    1. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
      S Kharbanda, Y Emoto, H Kisaki, A Saleem and D Kufe
      Molecular Pharmacology July 1994, 46 (1) 67-72;

  2. King, G R

    1. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
      C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood
      Molecular Pharmacology July 1994, 46 (1) 51-57;

  3. Kisaki, H

    1. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
      S Kharbanda, Y Emoto, H Kisaki, A Saleem and D Kufe
      Molecular Pharmacology July 1994, 46 (1) 67-72;

  4. Krause, J E

    1. Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708.
      B S Sachais and J E Krause
      Molecular Pharmacology July 1994, 46 (1) 122-128;

  5. Kufe, D

    1. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
      S Kharbanda, Y Emoto, H Kisaki, A Saleem and D Kufe
      Molecular Pharmacology July 1994, 46 (1) 67-72;

L

  1. Lanier, S M

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;

  2. Lazdunski, M

    1. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
      E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri
      Molecular Pharmacology July 1994, 46 (1) 139-145;

  3. Lee, K

    1. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
      K Lee, S E Ozanne, I C Rowe, C N Hales and M L Ashford
      Molecular Pharmacology July 1994, 46 (1) 176-185;

  4. Lee, T H

    1. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
      C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood
      Molecular Pharmacology July 1994, 46 (1) 51-57;

  5. Li, Q

    1. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
      T M Filtz, Q Li, J L Boyer, R A Nicholas and T K Harden
      Molecular Pharmacology July 1994, 46 (1) 8-14;

  6. Lindon, J C

    1. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
      M L Anthony, B C Sweatman, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology July 1994, 46 (1) 199-211;

M

  1. Maslanski, J A

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

  2. Mayer, M L

    1. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
      K M Partin, D K Patneau and M L Mayer
      Molecular Pharmacology July 1994, 46 (1) 129-138;

  3. McLane, M W

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

  4. Meisheri, K

    1. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
      E Guillemare, E Honore, J De Weille, M Fosset, M Lazdunski and K Meisheri
      Molecular Pharmacology July 1994, 46 (1) 139-145;

  5. Milligan, G

    1. The gonadotrophin-releasing hormone receptor of alpha T3-1 pituitary cells regulates cellular levels of both of the phosphoinositidase C-linked G proteins, Gq alpha and G11 alpha, equally.
      B H Shah and G Milligan
      Molecular Pharmacology July 1994, 46 (1) 1-7;

  6. Mitchelson, F

    1. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
      A Christopoulos and F Mitchelson
      Molecular Pharmacology July 1994, 46 (1) 105-114;

  7. Moore, W C

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

N

  1. Nelson, M E

    1. 9-Aminoacridines act at a site different from that for Mg2+ in blockade of the N-methyl-D-aspartate receptor channel.
      M E Nelson and E X Albuquerque
      Molecular Pharmacology July 1994, 46 (1) 151-160;

  2. Neumeyer, J L

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;

  3. Nicholas, R A

    1. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
      T M Filtz, Q Li, J L Boyer, R A Nicholas and T K Harden
      Molecular Pharmacology July 1994, 46 (1) 8-14;

  4. Nicholson, J K

    1. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
      M L Anthony, B C Sweatman, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology July 1994, 46 (1) 199-211;

  5. Norris, T E

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

O

  1. Ozanne, S E

    1. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
      K Lee, S E Ozanne, I C Rowe, C N Hales and M L Ashford
      Molecular Pharmacology July 1994, 46 (1) 176-185;

P

  1. Parini, A

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;

  2. Park-Chung, M

    1. 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons.
      M Park-Chung, F S Wu and D H Farb
      Molecular Pharmacology July 1994, 46 (1) 146-150;

  3. Partin, K M

    1. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
      K M Partin, D K Patneau and M L Mayer
      Molecular Pharmacology July 1994, 46 (1) 129-138;

  4. Patneau, D K

    1. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
      K M Partin, D K Patneau and M L Mayer
      Molecular Pharmacology July 1994, 46 (1) 129-138;

  5. Perez, D M

    1. Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle.
      M T Piascik, M S Smith, E E Soltis and D M Perez
      Molecular Pharmacology July 1994, 46 (1) 30-40;

  6. Piascik, M T

    1. Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle.
      M T Piascik, M S Smith, E E Soltis and D M Perez
      Molecular Pharmacology July 1994, 46 (1) 30-40;

R

  1. Rauly, I

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

  2. Reinhold, W C

    1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
      N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
      Molecular Pharmacology July 1994, 46 (1) 73-78;

  3. Ritke, M K

    1. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
      M K Ritke, W P Allan, C Fattman, N N Gunduz and J C Yalowich
      Molecular Pharmacology July 1994, 46 (1) 58-66;

  4. Rogers, N E

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

  5. Rooney, A

    1. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
      M S Simonson and A Rooney
      Molecular Pharmacology July 1994, 46 (1) 41-50;

  6. Rowe, I C

    1. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
      K Lee, S E Ozanne, I C Rowe, C N Hales and M L Ashford
      Molecular Pharmacology July 1994, 46 (1) 176-185;

S

  1. Sachais, B S

    1. Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708.
      B S Sachais and J E Krause
      Molecular Pharmacology July 1994, 46 (1) 122-128;

  2. Saint-Laurent, N

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

  3. Saleem, A

    1. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
      S Kharbanda, Y Emoto, H Kisaki, A Saleem and D Kufe
      Molecular Pharmacology July 1994, 46 (1) 67-72;

  4. Sánchez-Margalet, V

    1. Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking.
      V Sánchez-Margalet, M Valle and R Goberna
      Molecular Pharmacology July 1994, 46 (1) 24-29;

  5. Shah, B H

    1. The gonadotrophin-releasing hormone receptor of alpha T3-1 pituitary cells regulates cellular levels of both of the phosphoinositidase C-linked G proteins, Gq alpha and G11 alpha, equally.
      B H Shah and G Milligan
      Molecular Pharmacology July 1994, 46 (1) 1-7;

  6. Shaw, P M

    1. Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells.
      P M Shaw, M C Weiss and M Adesnik
      Molecular Pharmacology July 1994, 46 (1) 79-87;

  7. Silvia, C P

    1. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
      C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood
      Molecular Pharmacology July 1994, 46 (1) 51-57;

  8. Simonson, M S

    1. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
      M S Simonson and A Rooney
      Molecular Pharmacology July 1994, 46 (1) 41-50;

  9. Slusher, B S

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

  10. Smith, M S

    1. Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle.
      M T Piascik, M S Smith, E E Soltis and D M Perez
      Molecular Pharmacology July 1994, 46 (1) 30-40;

  11. Soltis, E E

    1. Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle.
      M T Piascik, M S Smith, E E Soltis and D M Perez
      Molecular Pharmacology July 1994, 46 (1) 30-40;

  12. Susini, C

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

  13. Sweatman, B C

    1. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine.
      M L Anthony, B C Sweatman, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology July 1994, 46 (1) 199-211;

T

  1. Trepel, J B

    1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
      N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
      Molecular Pharmacology July 1994, 46 (1) 73-78;

V

  1. Valle, M

    1. Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking.
      V Sánchez-Margalet, M Valle and R Goberna
      Molecular Pharmacology July 1994, 46 (1) 24-29;

  2. Vaysse, N

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

  3. Vidal, A M

    1. Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel.
      J P Dilger and A M Vidal
      Molecular Pharmacology July 1994, 46 (1) 169-175;

  4. Vidal, C

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

W

  1. Weiss, M C

    1. Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells.
      P M Shaw, M C Weiss and M Adesnik
      Molecular Pharmacology July 1994, 46 (1) 79-87;

  2. Williams, K

    1. Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors.
      K Williams
      Molecular Pharmacology July 1994, 46 (1) 161-168;

  3. Wu, F S

    1. 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons.
      M Park-Chung, F S Wu and D H Farb
      Molecular Pharmacology July 1994, 46 (1) 146-150;

X

  1. Xue, Z Y

    1. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
      C P Silvia, G R King, T H Lee, Z Y Xue, M G Caron and E H Ellinwood
      Molecular Pharmacology July 1994, 46 (1) 51-57;

Y

  1. Yalowich, J C

    1. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
      M K Ritke, W P Allan, C Fattman, N N Gunduz and J C Yalowich
      Molecular Pharmacology July 1994, 46 (1) 58-66;

Z

  1. Zacco, A E

    1. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
      B S Slusher, A E Zacco, J A Maslanski, T E Norris, M W McLane, W C Moore, N E Rogers and L J Ignarro
      Molecular Pharmacology July 1994, 46 (1) 115-121;

  2. Zajac-Kaye, M

    1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
      N Ben-Baruch, W C Reinhold, N Alexandrova, I Ichinose, M Blake, J B Trepel and M Zajac-Kaye
      Molecular Pharmacology July 1994, 46 (1) 73-78;

  3. Zeggari, M

    1. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
      C Vidal, I Rauly, M Zeggari, N Delesque, J P Esteve, N Saint-Laurent, N Vaysse and C Susini
      Molecular Pharmacology July 1994, 46 (1) 97-104;

  4. Zhang, W

    1. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
      B Ivkovic, V Bakthavachalam, W Zhang, A Parini, D Diz, S Bosch, J L Neumeyer and S M Lanier
      Molecular Pharmacology July 1994, 46 (1) 15-23;
Back to top

In this issue

Advertisement